Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nanoparticles-a thoracic toxicology perspective.

Rodger Duffin1, Nicholas L Mills, Ken Donaldson

  • 1MRC/University of Edinburgh Centre for Inflammation Research, ELEGI Colt Laboratory, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, Scotland, UK. rodger.duffin@ed.ac.uk

Yonsei Medical Journal
|August 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Socioeconomic status, cardiovascular risk factors and coronary atherosclerosis: a SCOT-HEART trial analysis.

European journal of preventive cardiology·2025
Same author

Cardiac Troponin I and T Ratio and Risk of Cardiovascular or Non-Cardiovascular Events in a General Population.

Clinical chemistry·2025
Same author

Accelerated diagnostic pathways for myocardial infarction using a Siemens High-Sensitivity cardiac troponin I assay.

Clinical biochemistry·2025
Same author

Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland.

Lancet (London, England)·2025
Same author

Implications of a new clinical classification of acute myocardial infarction.

European heart journal. Acute cardiovascular care·2025
Same author

Impact of diabetes mellitus on coronary artery plaque characteristics and outcomes in the SCOT-HEART trial.

Journal of cardiovascular computed tomography·2025

Combustion-derived nanoparticles (CDNP) in urban air cause lung inflammation and oxidative stress, contributing to cardiovascular disease. These environmental nanoparticles also serve as models for understanding engineered nanoparticles.

Area of Science:

  • Environmental Health
  • Toxicology
  • Cardiovascular Science

Background:

  • Ambient urban air contains combustion-derived nanoparticles (CDNP), primarily ultrafine particles from various sources.
  • CDNP possess properties like surface area, organics, and metals that generate free radicals, inducing oxidative stress and inflammation.
  • Inflammation is a key factor in airway and cardiovascular diseases exacerbated by particulate matter (PM).

Purpose of the Study:

  • To explore the role of CDNP in the adverse health effects associated with increased PM exposure.
  • To explain epidemiological findings linking PM to cardiovascular disease through proposed mechanisms of CDNP action.
  • To bridge toxicological knowledge between environmental nanoparticles and engineered nanoparticles.

Main Methods:

Related Experiment Videos

  • Literature review of studies on CDNP composition, properties, and biological effects.
  • Analysis of epidemiological data correlating PM exposure with cardiovascular outcomes.
  • Formulation of hypotheses explaining NP action on lung inflammation, cardiovascular system, and circulation.

    • Main Results:

    • CDNP are implicated in lung inflammation and oxidative stress, contributing to cardiovascular disease development and exacerbation.
    • Proposed mechanisms include NP-induced lung inflammation affecting atheromatous plaques and clotting balance.
    • NP or their components may enter circulation, directly impacting vascular endothelium, plaques, clotting, and heart rhythm.

    Conclusions:

    • CDNP are significant contributors to the adverse cardiovascular effects of PM.
    • Environmental nanoparticles offer a toxicological model for understanding the less-understood effects of engineered nanoparticles.
    • Further research is needed to bridge the toxicological knowledge gap between environmental and engineered nanoparticles.